Dr. Vernon Wu

Dr. Vernon Wu is a board-certified hematologist-oncologist specializing in comprehensive cancer care with expertise in both solid tumors and hematologic malignancies. His clinical focus encompasses the diagnosis and treatment of leukemia, lymphoma, myeloma, and solid tumors, with particular emphasis on delivering personalized, evidence-based cancer therapies.

Dr. Wu's research portfolio demonstrates his commitment to advancing cancer treatment through translational medicine. His work includes developing novel anti-cancer peptides for pancreatic cancer, investigating post-bone marrow transplant anti-tumor cellular immunity, and establishing risk stratification protocols for smoldering multiple myeloma and follicular lymphoma. Additionally, he conducts critical research on healthcare disparities in rectal cancer, working to improve equitable access to quality cancer care across diverse populations.

Dr. Wu received his Bachelor of Arts from Harvard University and his Doctor of Medicine from Icahn School of Medicine at Mount Sinai. He completed his Internal Medicine residency at Stony Brook University Hospital, followed by his Hematology-Oncology fellowship at Northwell Health, where he received comprehensive training in medical oncology, hematologic malignancies, and bone marrow transplantation.

His research contributions have been presented at numerous national oncology conferences and published in peer-reviewed journals, reflecting his dedication to advancing the field of cancer medicine. Dr. Wu is committed to providing compassionate, multidisciplinary cancer care while contributing to the development of innovative treatments that improve patient outcomes.

Dr. Wu is fluent in English and conversational in Cantonese, enabling him to serve diverse patient populations with culturally sensitive care.